-
1دورية أكاديمية
المؤلفون: Tene O; Department of Psychiatry, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel.; Department of Psychiatry, Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel., Molad J; Department of Neurology, Tel Aviv Sourasky Medical Center, Tel Aviv, 64239, Israel., Rotschild O; Department of Neurology, Tel Aviv Sourasky Medical Center, Tel Aviv, 64239, Israel., Alpernas A; Department of Neurology, Tel Aviv Sourasky Medical Center, Tel Aviv, 64239, Israel., Hawwari M; Department of Neurology, Tel Aviv Sourasky Medical Center, Tel Aviv, 64239, Israel., Seyman E; Department of Neurology-Stroke, Rambam Medical Center, Haifa, Israel., Giladi N; Brain Institute, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel.; Department of Neurology, Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.; Sagol School of Neuroscience, Tel Aviv University, Tel Aviv, Israel., Hallevi H; Department of Neurology, Tel Aviv Sourasky Medical Center, Tel Aviv, 64239, Israel.; Department of Neurology, Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.; Sagol School of Neuroscience, Tel Aviv University, Tel Aviv, Israel., Assayag EB; Department of Neurology, Tel Aviv Sourasky Medical Center, Tel Aviv, 64239, Israel. einorba@tlvmc.gov.il.; Department of Neurology, Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel. einorba@tlvmc.gov.il.; Sagol School of Neuroscience, Tel Aviv University, Tel Aviv, Israel. einorba@tlvmc.gov.il.
المصدر: BMC neurology [BMC Neurol] 2024 Jun 06; Vol. 24 (1), pp. 190. Date of Electronic Publication: 2024 Jun 06.
نوع المنشور: Journal Article; Clinical Trial
بيانات الدورية: Publisher: BioMed Central Country of Publication: England NLM ID: 100968555 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-2377 (Electronic) Linking ISSN: 14712377 NLM ISO Abbreviation: BMC Neurol Subsets: MEDLINE
مواضيع طبية MeSH: Maraviroc*/administration & dosage , Maraviroc*/therapeutic use , CCR5 Receptor Antagonists*/therapeutic use , CCR5 Receptor Antagonists*/administration & dosage , Proof of Concept Study* , Stroke*/complications , Stroke*/psychology , Stroke*/drug therapy, Humans ; Male ; Female ; Middle Aged ; Aged ; Depression/drug therapy ; Depression/etiology ; Treatment Outcome ; Triazoles/therapeutic use ; Triazoles/administration & dosage ; Adult ; Receptors, CCR5/metabolism
-
2دورية أكاديميةCCR2/CCR5 antagonist cenicriviroc reduces colonic inflammation and fibrosis in experimental colitis.
المؤلفون: Song X; Department of Gastroenterology, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China., Jiang C; Department of Gastroenterology, The Fourth Affiliated Hospital, Zhejiang University School of Medicine, Yiwu, China., Yu M; Department of Gastroenterology, The Fourth Affiliated Hospital, Zhejiang University School of Medicine, Yiwu, China., Lu C; Department of Gastroenterology, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China., He X; Department of Gastroenterology, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.
المصدر: Journal of gastroenterology and hepatology [J Gastroenterol Hepatol] 2024 Aug; Vol. 39 (8), pp. 1597-1605. Date of Electronic Publication: 2024 May 14.
نوع المنشور: Journal Article
بيانات الدورية: Publisher: Blackwell Scientific Publications Country of Publication: Australia NLM ID: 8607909 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1440-1746 (Electronic) Linking ISSN: 08159319 NLM ISO Abbreviation: J Gastroenterol Hepatol Subsets: MEDLINE
مواضيع طبية MeSH: Colitis*/drug therapy , Colitis*/pathology , Colitis*/chemically induced , Disease Models, Animal* , Receptors, CCR2*/metabolism , Receptors, CCR2*/antagonists & inhibitors , Fibrosis* , CCR5 Receptor Antagonists*/pharmacology , Colon*/pathology , Colon*/drug effects, Animals ; Humans ; Receptors, CCR5/metabolism ; HT29 Cells ; Tumor Necrosis Factor-alpha/metabolism ; Mice ; Male ; Chemokine CCL5/metabolism ; Mice, Inbred C57BL ; Chronic Disease ; Dextran Sulfate ; Imidazoles ; Sulfoxides
-
3دورية أكاديمية
المؤلفون: Gracias S; Univ Rouen Normandie, Université de Caen Normandie, INSERM, Normandie Univ, DYNAMICURE UMR 1311, CHU Rouen, Department of virology, Rouen, France., El Yaalaoui I; Univ Rouen Normandie, Université de Caen Normandie, INSERM, Normandie Univ, DYNAMICURE UMR 1311, CHU Rouen, Department of virology, Rouen, France., Visseaux B; Service de virologie, IAME, INSERM, UMR 1137, AP-HP, Hôpital Bichat-Claude Bernard, Université Paris Cité, Paris, France., Charpentier C; Service de virologie, IAME, INSERM, UMR 1137, AP-HP, Hôpital Bichat-Claude Bernard, Université Paris Cité, Paris, France., Descamps D; Service de virologie, IAME, INSERM, UMR 1137, AP-HP, Hôpital Bichat-Claude Bernard, Université Paris Cité, Paris, France., Martin C; Univ Rouen Normandie, Université de Caen Normandie, INSERM, Normandie Univ, DYNAMICURE UMR 1311, CHU Rouen, Department of virology, Rouen, France., Lermechain F; Univ Rouen Normandie, Université de Caen Normandie, INSERM, Normandie Univ, DYNAMICURE UMR 1311, CHU Rouen, Department of virology, Rouen, France., Plantier J-C; Univ Rouen Normandie, Université de Caen Normandie, INSERM, Normandie Univ, DYNAMICURE UMR 1311, CHU Rouen, Department of virology, Rouen, France., Alessandri-Gradt E; Univ Rouen Normandie, Université de Caen Normandie, INSERM, Normandie Univ, DYNAMICURE UMR 1311, CHU Rouen, Department of virology, Rouen, France.
المصدر: Microbiology spectrum [Microbiol Spectr] 2024 Jul 02; Vol. 12 (7), pp. e0389523. Date of Electronic Publication: 2024 May 29.
نوع المنشور: Journal Article
بيانات الدورية: Publisher: ASM Press Country of Publication: United States NLM ID: 101634614 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2165-0497 (Electronic) Linking ISSN: 21650497 NLM ISO Abbreviation: Microbiol Spectr Subsets: MEDLINE
مواضيع طبية MeSH: HIV-1*/drug effects , HIV-1*/genetics , HIV-1*/physiology , Maraviroc*/pharmacology , CCR5 Receptor Antagonists*/pharmacology , HIV Infections*/virology , HIV Infections*/drug therapy , Viral Tropism*, Humans ; Inhibitory Concentration 50 ; Triazoles/pharmacology ; Phenotype ; Microbial Sensitivity Tests ; Receptors, CCR5/metabolism ; Receptors, CCR5/genetics ; Anti-HIV Agents/pharmacology ; Cyclohexanes/pharmacology ; Drug Resistance, Viral/genetics ; HIV Fusion Inhibitors/pharmacology
-
4دورية أكاديمية
المؤلفون: Wu Y; Department of Anesthesiology, Shanghai Cancer Center, Fudan University, Shanghai, 200032, PR China., Che J; Department of Anesthesiology, Shanghai Cancer Center, Fudan University, Shanghai, 200032, PR China., Dong J; Department of Anesthesiology, Shanghai Cancer Center, Fudan University, Shanghai, 200032, PR China., Zhang X; Department of Anesthesiology, Shanghai Cancer Center, Fudan University, Shanghai, 200032, PR China., Deng Y; Department of Anesthesiology, Shanghai Cancer Center, Fudan University, Shanghai, 200032, PR China., Chen W; Department of Anesthesiology, Shanghai Cancer Center, Fudan University, Shanghai, 200032, PR China., Zhang J; Department of Anesthesiology, Shanghai Cancer Center, Fudan University, Shanghai, 200032, PR China; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, 200032, PR China. Electronic address: snapzhang@aliyun.com.
المصدر: Neuropharmacology [Neuropharmacology] 2024 Aug 15; Vol. 254, pp. 109981. Date of Electronic Publication: 2024 May 03.
نوع المنشور: Journal Article
بيانات الدورية: Publisher: Pergamon Press Country of Publication: England NLM ID: 0236217 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1873-7064 (Electronic) Linking ISSN: 00283908 NLM ISO Abbreviation: Neuropharmacology Subsets: MEDLINE
مواضيع طبية MeSH: Maraviroc*/pharmacology , CCR5 Receptor Antagonists*/pharmacology , Doxorubicin* , NLR Family, Pyrin Domain-Containing 3 Protein*/metabolism , NLR Family, Pyrin Domain-Containing 3 Protein*/antagonists & inhibitors , NF-kappa B*/metabolism , Signal Transduction*/drug effects , Mice, Inbred C57BL*, Animals ; Mice ; Female ; Neuroinflammatory Diseases/drug therapy ; Neuroinflammatory Diseases/chemically induced ; Breast Neoplasms/drug therapy ; Hippocampus/drug effects ; Hippocampus/metabolism ; Antibiotics, Antineoplastic/toxicity ; Chemotherapy-Related Cognitive Impairment/drug therapy ; Receptors, CCR5/metabolism ; Neuroprotective Agents/pharmacology ; Cognitive Dysfunction/drug therapy ; Cognitive Dysfunction/chemically induced ; Cognitive Dysfunction/metabolism
-
5Editorial & Opinion
المؤلفون: Brata VD; Department of Hepatology & Gastroenterology, Charité Universitätsmedizin, Berlin, Germany.; Faculty of Medicine, 'Iuliu Hatieganu' University of Medicine and Pharmacy, Cluj-Napoca, Romania., Tacke F; Department of Hepatology & Gastroenterology, Charité Universitätsmedizin, Berlin, Germany.
المصدر: Expert opinion on therapeutic targets [Expert Opin Ther Targets] 2024 May; Vol. 28 (5), pp. 335-339. Date of Electronic Publication: 2024 Jun 13.
نوع المنشور: Editorial
بيانات الدورية: Publisher: Informa Healthcare Country of Publication: England NLM ID: 101127833 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1744-7631 (Electronic) Linking ISSN: 14728222 NLM ISO Abbreviation: Expert Opin Ther Targets Subsets: MEDLINE
-
6دورية أكاديمية
المؤلفون: Amorim Sacramento L; Department of Pathobiology, School of Veterinary Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, United States of America., Farias Amorim C; Department of Pathobiology, School of Veterinary Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, United States of America., G Lombana C; Department of Pathobiology, School of Veterinary Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, United States of America., Beiting D; Department of Pathobiology, School of Veterinary Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, United States of America., Novais F; Department of Microbial Infection and Immunity, College of Medicine, The Ohio State University, Columbus, Ohio, United States of America., P Carvalho L; Laboratório de Pesquisas Clínicas do Instituto de Pesquisas Gonçalo Muniz-Fiocruz, Salvador, Bahia, Brazil.; Immunology Service, Professor Edgard Santos University Hospital Complex, Federal University of Bahia, Salvador, Bahia, Brazil., M Carvalho E; Laboratório de Pesquisas Clínicas do Instituto de Pesquisas Gonçalo Muniz-Fiocruz, Salvador, Bahia, Brazil.; Immunology Service, Professor Edgard Santos University Hospital Complex, Federal University of Bahia, Salvador, Bahia, Brazil., Scott P; Department of Pathobiology, School of Veterinary Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, United States of America.
المصدر: PLoS pathogens [PLoS Pathog] 2024 May 06; Vol. 20 (5), pp. e1012211. Date of Electronic Publication: 2024 May 06 (Print Publication: 2024).
نوع المنشور: Journal Article
بيانات الدورية: Publisher: Public Library of Science Country of Publication: United States NLM ID: 101238921 Publication Model: eCollection Cited Medium: Internet ISSN: 1553-7374 (Electronic) Linking ISSN: 15537366 NLM ISO Abbreviation: PLoS Pathog Subsets: MEDLINE
مواضيع طبية MeSH: Receptors, CCR5*/metabolism , Receptors, CCR5*/immunology , CD8-Positive T-Lymphocytes*/immunology , Cell Movement* , Leishmaniasis, Cutaneous*/immunology , Leishmaniasis, Cutaneous*/parasitology , Leishmaniasis, Cutaneous*/pathology, Animals ; Mice ; Humans ; Mice, Knockout ; Mice, Inbred C57BL ; CCR5 Receptor Antagonists/pharmacology ; Maraviroc/pharmacology ; Female
-
7دورية أكاديمية
المؤلفون: Elliott Williams M; Department of Microbiology & Immunology, Emory University School of Medicine, Atlanta, GA, USA., Hardnett FP; Division of HIV Prevention, Centers for Disease Control and Prevention, Atlanta, GA, USA., Sheth AN; Department of Medicine, Division of Infectious Diseases, Emory University School of Medicine and Grady Health System, Atlanta, GA, USA., Wein AN; Department of Microbiology & Immunology, Emory University School of Medicine, Atlanta, GA, USA., Li ZT; Department of Microbiology & Immunology, Emory University School of Medicine, Atlanta, GA, USA., Radzio-Basu J; Division of HIV Prevention, Centers for Disease Control and Prevention, Atlanta, GA, USA., Dinh C; Division of HIV Prevention, Centers for Disease Control and Prevention, Atlanta, GA, USA., Haddad LB; Department of Gynecology & Obstetrics, Emory University School of Medicine, Atlanta, GA, USA., Collins EMB; Department of Gynecology & Obstetrics, Emory University School of Medicine, Atlanta, GA, USA., Ofotokun I; Department of Medicine, Division of Infectious Diseases, Emory University School of Medicine and Grady Health System, Atlanta, GA, USA., Antia R; Department of Biology, Emory University, Atlanta, GA, USA., Scharer CD; Department of Microbiology & Immunology, Emory University School of Medicine, Atlanta, GA, USA., Garcia-Lerma JG; Division of HIV Prevention, Centers for Disease Control and Prevention, Atlanta, GA, USA., Kohlmeier JE; Department of Microbiology & Immunology, Emory University School of Medicine, Atlanta, GA, USA., Swaims-Kohlmeier A; Department of Microbiology & Immunology, Emory University School of Medicine, Atlanta, GA, USA; Division of HIV Prevention, Centers for Disease Control and Prevention, Atlanta, GA, USA; Department of Gynecology & Obstetrics, Emory University School of Medicine, Atlanta, GA, USA. Electronic address: askohlm@emory.edu.
المصدر: Mucosal immunology [Mucosal Immunol] 2024 Feb; Vol. 17 (1), pp. 41-53. Date of Electronic Publication: 2023 Oct 20.
نوع المنشور: Journal Article
بيانات الدورية: Publisher: Elsevier Country of Publication: United States NLM ID: 101299742 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1935-3456 (Electronic) Linking ISSN: 19330219 NLM ISO Abbreviation: Mucosal Immunol Subsets: MEDLINE
مواضيع طبية MeSH: CD4-Positive T-Lymphocytes*/cytology , CD4-Positive T-Lymphocytes*/drug effects , CD4-Positive T-Lymphocytes*/immunology , Genitalia, Female*/immunology , Genitalia, Female*/metabolism , Menstrual Cycle*/immunology , Menstrual Cycle*/physiology , Receptors, CCR5*/genetics , Receptors, CCR5*/metabolism , Signal Transduction*, Female ; Humans ; T-Lymphocyte Subsets/immunology ; Macaca nemestrina/immunology ; Immunologic Memory ; Cellular Microenvironment/immunology ; Cellular Microenvironment/physiology ; CCR5 Receptor Antagonists/pharmacology
-
8دورية أكاديمية
المؤلفون: Wu QL; Clinical Pharmacology Institute, Guangzhou University of Chinese Medicine, Guangzhou, 510405, China., Cui LY; State Key Laboratory of Bioactive Substances and Functions of Natural Medicines, Institute of Materia Medica, Neuroscience Center, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100050, China., Ma WY; Clinical Pharmacology Institute, Guangzhou University of Chinese Medicine, Guangzhou, 510405, China., Wang SS; Clinical Pharmacology Institute, Guangzhou University of Chinese Medicine, Guangzhou, 510405, China., Zhang Z; State Key Laboratory of Bioactive Substances and Functions of Natural Medicines, Institute of Materia Medica, Neuroscience Center, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100050, China., Feng ZP; Department of Physiology, Temerty Faculty of Medicine, University of Toronto, 1 King's College Circle, Toronto, ON, M5S 1A8, Canada., Sun HS; Department of Physiology, Temerty Faculty of Medicine, University of Toronto, 1 King's College Circle, Toronto, ON, M5S 1A8, Canada., Chu SF; State Key Laboratory of Bioactive Substances and Functions of Natural Medicines, Institute of Materia Medica, Neuroscience Center, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100050, China. chushifeng@imm.ac.cn., He WB; Shanxi Key Laboratory of Chinese Medicine Encephalopathy, Shanxi University of Chinese Medicine, Taiyuan, 030024, China. hewb@sxtcm.edu.cn.; National International Joint Research Center for Molecular Chinese Medicine, Shanxi University of Chinese Medicine, Taiyuan, 030024, China. hewb@sxtcm.edu.cn., Chen NH; Clinical Pharmacology Institute, Guangzhou University of Chinese Medicine, Guangzhou, 510405, China. chennh@imm.ac.cn.; State Key Laboratory of Bioactive Substances and Functions of Natural Medicines, Institute of Materia Medica, Neuroscience Center, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100050, China. chennh@imm.ac.cn.
المصدر: Acta pharmacologica Sinica [Acta Pharmacol Sin] 2023 Oct; Vol. 44 (10), pp. 1935-1947. Date of Electronic Publication: 2023 May 17.
نوع المنشور: Journal Article
بيانات الدورية: Publisher: Nature Publishing Group Country of Publication: United States NLM ID: 100956087 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1745-7254 (Electronic) Linking ISSN: 16714083 NLM ISO Abbreviation: Acta Pharmacol Sin Subsets: MEDLINE
مواضيع طبية MeSH: Ischemic Stroke*/drug therapy , Neuroblastoma* , Stroke*/drug therapy , CCR5 Receptor Antagonists*/chemistry , CCR5 Receptor Antagonists*/pharmacology, Animals ; Humans ; Mice ; Maraviroc/therapeutic use ; Maraviroc/pharmacology ; Molecular Docking Simulation ; Receptors, CCR5/metabolism
-
9دورية أكاديمية
المؤلفون: Matsuda M; Laboratory Immunopharmacology, Faculty of Pharmaceutical Sciences, Setsunan University, Osaka 573-0101, Japan., Shimora H; Laboratory Immunopharmacology, Faculty of Pharmaceutical Sciences, Setsunan University, Osaka 573-0101, Japan., Nagatani Y; Laboratory Immunopharmacology, Faculty of Pharmaceutical Sciences, Setsunan University, Osaka 573-0101, Japan., Nishikawa K; Laboratory Immunopharmacology, Faculty of Pharmaceutical Sciences, Setsunan University, Osaka 573-0101, Japan., Takamori I; Laboratory Immunopharmacology, Faculty of Pharmaceutical Sciences, Setsunan University, Osaka 573-0101, Japan., Haguchi T; Laboratory Immunopharmacology, Faculty of Pharmaceutical Sciences, Setsunan University, Osaka 573-0101, Japan., Kitatani K; Laboratory Immunopharmacology, Faculty of Pharmaceutical Sciences, Setsunan University, Osaka 573-0101, Japan., Kaminuma O; Department of Disease Model, Research Institute of Radiation Biology and Medicine, Hiroshima University, Hiroshima 734-8551, Japan., Nabe T; Laboratory Immunopharmacology, Faculty of Pharmaceutical Sciences, Setsunan University, Osaka 573-0101, Japan. Electronic address: t-nabe@pharm.setsunan.ac.jp.
المصدر: International immunopharmacology [Int Immunopharmacol] 2024 Jun 30; Vol. 135, pp. 112331. Date of Electronic Publication: 2024 May 24.
نوع المنشور: Journal Article
بيانات الدورية: Publisher: Elsevier Science Country of Publication: Netherlands NLM ID: 100965259 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1878-1705 (Electronic) Linking ISSN: 15675769 NLM ISO Abbreviation: Int Immunopharmacol Subsets: MEDLINE
مواضيع طبية MeSH: Asthma*/immunology , Asthma*/drug therapy , Asthma*/pathology , Asthma*/metabolism , Receptors, CCR5*/metabolism , Receptors, CCR5*/genetics , Maraviroc*/pharmacology , Maraviroc*/therapeutic use , CCR5 Receptor Antagonists*/pharmacology , CCR5 Receptor Antagonists*/therapeutic use , Macrophages*/immunology , Macrophages*/drug effects , Transforming Growth Factor beta*/metabolism , Pulmonary Fibrosis*/immunology , Pulmonary Fibrosis*/pathology , Pulmonary Fibrosis*/metabolism , Pulmonary Fibrosis*/drug therapy, Animals ; Mice ; Lung/pathology ; Lung/immunology ; Lung/drug effects ; Mice, Inbred BALB C ; Disease Models, Animal ; Humans ; Female
-
10دورية أكاديمية
المؤلفون: Kumar A; Department of Microbiology & Clinical Parasitology, College of Medicine, King Khalid University, Abha, Saudi Arabia.
المصدر: Biotechnology and applied biochemistry [Biotechnol Appl Biochem] 2024 Aug; Vol. 71 (4), pp. 849-859. Date of Electronic Publication: 2024 Mar 31.
نوع المنشور: Journal Article
بيانات الدورية: Publisher: Wiley-Blackwell Country of Publication: United States NLM ID: 8609465 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1470-8744 (Electronic) Linking ISSN: 08854513 NLM ISO Abbreviation: Biotechnol Appl Biochem Subsets: MEDLINE
مواضيع طبية MeSH: CCR5 Receptor Antagonists*/pharmacology , CCR5 Receptor Antagonists*/chemistry , Anti-HIV Agents*/pharmacology , Anti-HIV Agents*/chemistry , Anti-HIV Agents*/metabolism , Receptors, CCR5*/metabolism, Humans ; Animals ; HIV-1/drug effects ; Chlorocebus aethiops ; Molecular Dynamics Simulation ; Vero Cells ; Maraviroc/pharmacology ; Maraviroc/chemistry ; Dose-Response Relationship, Drug ; Leukocytes, Mononuclear/drug effects ; Leukocytes, Mononuclear/metabolism ; Leukocytes, Mononuclear/virology ; HIV Infections/drug therapy ; HIV Infections/metabolism